BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 28750504)

  • 1. Does myofascial and trigger point treatment reduce pain and analgesic intake in patients undergoing onabotulinumtoxinA injection due to chronic intractable migraine?
    Gandolfi M; Geroin C; Valè N; Marchioretto F; Turrina A; Dimitrova E; Tamburin S; Serina A; Castellazzi P; Meschieri A; Ricard F; Saltuari L; Picelli A; Smania N
    Eur J Phys Rehabil Med; 2018 Feb; 54(1):1-12. PubMed ID: 28750504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of burst-type transcutaneous electrical nerve stimulation on cervical range of motion and latent myofascial trigger point pain sensitivity.
    Rodríguez-Fernández AL; Garrido-Santofimia V; Güeita-Rodríguez J; Fernández-de-Las-Peñas C
    Arch Phys Med Rehabil; 2011 Sep; 92(9):1353-8. PubMed ID: 21878204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program.
    Dodick DW; Turkel CC; DeGryse RE; Aurora SK; Silberstein SD; Lipton RB; Diener HC; Brin MF;
    Headache; 2010 Jun; 50(6):921-36. PubMed ID: 20487038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
    Seo HG; Bang MS; Chung SG; Jung SH; Lee SU
    Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.
    Harden RN; Cottrill J; Gagnon CM; Smitherman TA; Weinland SR; Tann B; Joseph P; Lee TS; Houle TT
    Headache; 2009 May; 49(5):732-43. PubMed ID: 19178577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
    Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
    Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate effect of electric point stimulation (TENS) in treating latent upper trapezius trigger points: a double blind randomised placebo-controlled trial.
    Gemmell H; Hilland A
    J Bodyw Mov Ther; 2011 Jul; 15(3):348-54. PubMed ID: 21665112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study.
    Blumenfeld AM; Stark RJ; Freeman MC; Orejudos A; Manack Adams A
    J Headache Pain; 2018 Feb; 19(1):13. PubMed ID: 29404713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in a patient with neck pain after application of ischemic compression as a trigger point therapy.
    Montañez-Aguilera FJ; Valtueña-Gimeno N; Pecos-Martín D; Arnau-Masanet R; Barrios-Pitarque C; Bosch-Morell F
    J Back Musculoskelet Rehabil; 2010; 23(2):101-4. PubMed ID: 20555123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short- and medium-term effects of manual therapy on cervical active range of motion and pressure pain sensitivity in latent myofascial pain of the upper trapezius muscle: a randomized controlled trial.
    Oliveira-Campelo NM; de Melo CA; Alburquerque-Sendín F; Machado JP
    J Manipulative Physiol Ther; 2013 Jun; 36(5):300-9. PubMed ID: 23769263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine.
    Cady RK; Schreiber CP; Porter JA; Blumenfeld AM; Farmer KU
    Headache; 2011 Jan; 51(1):21-32. PubMed ID: 21070228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.
    Mathew NT; Jaffri SF
    Headache; 2009; 49(10):1466-78. PubMed ID: 19912346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
    Aurora SK; Winner P; Freeman MC; Spierings EL; Heiring JO; DeGryse RE; VanDenburgh AM; Nolan ME; Turkel CC
    Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myofascial trigger points in migraine and tension-type headache.
    Do TP; Heldarskard GF; Kolding LT; Hvedstrup J; Schytz HW
    J Headache Pain; 2018 Sep; 19(1):84. PubMed ID: 30203398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Botulinum type A toxin complex for the relief of upper back myofascial pain syndrome: how do fixed-location injections compare with trigger point-focused injections?
    Benecke R; Heinze A; Reichel G; Hefter H; Göbel H;
    Pain Med; 2011 Nov; 12(11):1607-14. PubMed ID: 21692970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of chronic migraine headache with onabotulinumtoxinA.
    Gerwin R
    Curr Pain Headache Rep; 2011 Oct; 15(5):336-8. PubMed ID: 21547527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alleviation of migraine symptoms by application of repetitive peripheral magnetic stimulation to myofascial trigger points of neck and shoulder muscles - A randomized trial.
    Renner T; Sollmann N; Heinen F; Albers L; Trepte-Freisleder F; Klose B; König H; Krieg SM; Bonfert MV; Landgraf MN
    Sci Rep; 2020 Apr; 10(1):5954. PubMed ID: 32249788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Injection in the cervical facet joint for shoulder pain with myofascial trigger points in the upper trapezius muscle.
    Tsai CT; Hsieh LF; Kuan TS; Kao MJ; Hong CZ
    Orthopedics; 2009 Aug; 32(8):. PubMed ID: 19708635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contribution of myofascial trigger points to migraine symptoms.
    Giamberardino MA; Tafuri E; Savini A; Fabrizio A; Affaitati G; Lerza R; Di Ianni L; Lapenna D; Mezzetti A
    J Pain; 2007 Nov; 8(11):869-78. PubMed ID: 17690015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of simultaneous administration of occipital nerve block and cervical myofascial trigger point injection (MTrPI) on headache parameters in chronic migraine patients.
    Ercan M; Ertekin A
    Ir J Med Sci; 2024 Mar; ():. PubMed ID: 38451438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.